The largest database of trusted experimental protocols

Topotecan tpt

Manufactured by Merck Group
Sourced in Ireland

Topotecan (TPT) is a type of laboratory equipment used in scientific research and development. It is a chemical compound that functions as a topoisomerase I inhibitor, which plays a crucial role in cellular processes such as DNA replication and transcription. Topotecan is a widely used tool in various biomedical research applications, including the study of cancer biology and the development of new therapeutic agents.

Automatically generated - may contain errors

2 protocols using topotecan tpt

1

Dose-response Curves for Plasma-Activated Water and Topotecan

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dose–response curves for glow and spark PAW, and topotecan (TPT) (Sigma-Aldrich, Arklow, Ireland) were established. TPT was dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich, Arklow, Ireland) at a final concentration of 1 mM and stored at −20 °C. This stock was subsequently used to make the working standard solutions in media. The highest concentration of DMSO used was a 5 µM final concentration. Existing media were removed from each well and cells were treated with either PAW, TPT or solvent control (DMSO) and incubated for 72 h. No deleterious effects were observed from the control solvent (range of concentrations between 0.02 nM and 5 µM). Dose–response curves were established for the final % (v/v) of PAW (spark discharge—1 to 10%; glow discharge—5 to 40%), and the final concentration (nM) of TPT (500.00, 250.00, 125.00, 62.50, 31.25, 15.62, 7.81, 3.91, 1.95, 0.98, 0.49, 0.24, 0.12, 0.06, 0.03, 0.015, 0.008, 0.004 and 0.002 for U-251mg cell line and 250.00, 125.00, 62.50, 31.25, 15.62, 7.81, 3.91, 1.95, 0.98, 0.49, 0.24, 0.12, 0.06, 0.03, 0.015, 0.008 and 0.004 for A172 cell line) in each well.
+ Open protocol
+ Expand
2

Topotecan-Induced R-loop Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to exacerbate the formation of R-loops and determine whether R-loop could form in post-mitotic tissues upon DNA damage accumulation, ARCA mouse models were treated with Topotecan (TPT) (Sigma-Aldrich), a water-soluble derivative of camptothecin for a period of 9 days. Topotecan was administered daily (approximately at 10:00 am) as an intraperitoneal injection following a brief anaesthesia using Isofluorane gas (2.5% at 3 L/min). Isofluorane is one of the safest methods recognised for rodents anaesthesia. For each genotype group, 3 mice were injected daily either with carrier solution (Sterile Injection Water BP, Pfizer) or TPT (2 mg/Kg/Day) and weight was monitored and recorded daily prior and 24 hours post injection. Animal weights were recorded prior, during, and after the treatment regimen. General health and behaviour of the mice was monitored daily until the end of the treatment when the animals were sacrificed to assess for R-loop formation, apoptosis levels and proliferation status.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!